SCHEMBL2472999

SCHEMBL2472999

CNC(=O)Nc1nc(N)nc(NC(=O)NC)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
RECQL P46063 1/20 0.39
PIK3CA P42336 3/20 0.38
MTOR P42345 3/20 0.38
PIK3R1 P27986 1/20 0.38
KMT2A Q03164 1/20 0.35
POLB P06746 3/20 0.35
TDP1 Q9NUW8 1/20 0.35
PIK3CG P48736 2/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CB P42338 1/20 0.33
HSP90AB1 P08238 1/20 0.33
JAK1 P23458 1/20 0.33
MAPT P10636 1/20 0.32
MAPKAPK2 P49137 1/20 0.31
FGFR1 P11362 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7186156 0.96 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2RECQLPIK3CAMTOR
SCHEMBL2478969 0.89 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2RECQLPIK3CAMTOR
SCHEMBL2475847 0.84 POLB (0.51) ALDH1A1SMN1; SMN2PIK3CAMTORPIK3R1
SCHEMBL9989022 0.81 PIK3R1 (0.35) PIK3CAMTORPIK3R1
SCHEMBL19175734 0.80 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2RECQLPIK3CAMTOR
SCHEMBL20063055 0.79 POLB (0.42) ALDH1A1PIK3CAMTORPIK3R1POLB
SCHEMBL20457039 0.78 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2RECQLPIK3CAMTOR
SCHEMBL13554533 0.77 POLB (0.52) ALDH1A1POLBMAPT
SCHEMBL12971786 0.75 POLB (0.46) ALDH1A1POLB
SCHEMBL19175466 0.75 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2RECQLPIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373633-B1 METHOD FOR PRODUCING TRAZINE CARBAMATES USING CHLOROFORMATES BOREALIS AGROLINZ MELAMINE (AT) 2014-04-16 EP disclosed
US-20110295001-A1 Method for Producing Triazine Carbamates Using Chloroformates BOREALIS AGROLINZ MELAMINE GMBH (AT) 2011-12-01 US disclosed
EP-2373633-A1 METHOD FOR PRODUCING TRAZINE CARBAMATES USING CHLOROFORMATES Borealis Agrolinz Melamine GmbH (AT) 2011-10-12 EP disclosed
WO-2010066683-A1 METHOD FOR PRODUCING TRAZINE CARBAMATES USING CHLOROFORMATES BOREALIS AGROLINZ MELAMINE GMBH (AT) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110295001-A1 Method for Producing Triazine Carbamates Using Chloroformates CA3, CA7, KAT5 ALDH1A1 1014/4885SMN1; SMN2 4704/4885RECQL 4833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.